Mostrar el registro sencillo del ítem
Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report
dc.contributor.author | Spuch, C. | |
dc.contributor.author | López-García, M. | |
dc.contributor.author | Rivera-Baltanás, T. | |
dc.contributor.author | Rodrígues-Amorím, D. | |
dc.contributor.author | Olivares Diez, José Manuel | |
dc.date.accessioned | 2022-05-24T12:13:49Z | |
dc.date.available | 2022-05-24T12:13:49Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 1663-9812 | |
dc.identifier.other | https://www.ncbi.nlm.nih.gov/pubmed/32973537 | es |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/16825 | |
dc.description.abstract | Lithium has shown the capacity to: a) inhibit the replication of several types of viruses, some of which are similar to the SARS-CoV-2 virus, b) increase the immune response by reducing lymphopenia, and c) reduce inflammation by preventing or reducing the cytokine storm. In the present study, we have treated six patients with severe COVID-19 infection with lithium carbonate. We found that lithium carbonate significantly reduced plasma reactive C-Protein levels, increased lymphocyte numbers and decreased the neutrophil-lymphocyte ratio, improving both inflammatory activity and the immune response in these patients. We propose that lithium carbonate may deserve a place in the treatment against COVID-19. | en |
dc.rights | Atribución 4.0 Internacional | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject.mesh | Lithium Carbonate | * |
dc.subject.mesh | Inflammation | * |
dc.title | Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report | en |
dc.type | Journal Article | es |
dc.authorsophos | Spuch, C.;López-García, M.;Rivera-Baltanás, T.;Rodrígues-Amorím, D.;Olivares, J. M. | |
dc.identifier.doi | 10.3389/fphar.2020.557629 | |
dc.identifier.pmid | 32973537 | |
dc.identifier.sophos | 41540 | |
dc.journal.title | FRONTIERS IN PHARMACOLOGY | es |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Vigo - Complexo Hospitalario Universitario de Vigo::Psiquiatría | es |
dc.page.initial | 557629 | es |
dc.relation.publisherversion | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481472/pdf/fphar-11-557629.pdf | es |
dc.rights.accessRights | openAccess | |
dc.subject.decs | inflamación | * |
dc.subject.decs | carbonato de litio | * |
dc.subject.keyword | CHUVI | es |
dc.typefides | Artículo Original | es |
dc.typesophos | Artículo Original | es |
dc.volume.number | 11 | es |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
![](/xmlui/themes/Mirage2//images/final_lines.png)